Sirolimus 2 MG

DRUG2 trials

Sponsors

NYU Langone Health, ANRS, Emerging Infectious Diseases

Conditions

HIV-1-infectionMultiple System Atrophy

Phase 2

A Futility Trial of Sirolimus in Multiple System Atrophy

TerminatedNCT03589976

NYU Langone HealthMultiple System Atrophy

Start: 2018-09-01End: 2021-01-01Updated: 2021-12-07

Immunotherapy With Baricitinib and Sirolimus, Alone and in Combination, for the Control of HIV-1 Replication After Antiretroviral Treatment Interruption

Not yet recruitingNCT07081763

ANRS, Emerging Infectious DiseasesHIV-1-infection

Start: 2026-05-31End: 2030-11-30Target: 191Updated: 2025-07-23

Related Papers

<scp>mTOR</scp> Inhibition with Sirolimus in Multiple System Atrophy: A Randomized, Double‐Blind, Placebo‐Controlled Futility Trial and 1‐Year Biomarker Longitudinal Analysis

Movement Disorders2022-01-1834 citations

A Futility Trial of Sirolimus in Multiple System Atrophy: Protocol, Recruitment and Preliminary Adverse Event Profile (P3.8-019)

Neurology2019-04-094 citations